This federal contract award, HHSN275201600103P, was issued by the National Institute of Child Health and Human Development, a civilian agency, to Particle Sciences, Inc. (doing business as NPR Healthcare), a subsidiary of Berkshire Hathaway Inc. The $75,661.73 firm-fixed-price purchase order does not have a set-aside designation and is focused on the "METHYLPHENIDATE CATALOG" major program. The ultimate completion date for this contract is May 28, 2021. Berkshire Hathaway, a...
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $30,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey for the synthesis of synthetic compounds to support NCATS. Under the terms of the award, Medchemexpress will provide synthetic compound synthesis services to NCATS by November 11, 2022. No set-aside provisions were applied to this procurement. As the lead institute for NIH's translational...
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $149,600.00 firm-fixed-price purchase order contract to Specs Chemical Services, Inc., a small disadvantaged business, to provide a "Pharmacologically Active Chemical Toolbox (NPACT) Commercial Powder Reformatting to Solutions" service. The contract has an ultimate completion date of March 31, 2016 and was awarded on August 13, 2015. The contract was not set aside for any...
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Compound Focus Inc. for the operation and maintenance of the NCATS Small Molecule Repository. The contract has a ceiling value of $2,093,753.88 and was awarded on June 14, 2016, with a period of performance through June 13, 2017. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type, and there is no set-aside designation. The contract is not...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $391,467 firm fixed price purchase order to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, to acquire 97 specified chemical compounds for NCATS' pre-clinical library in support of its antiviral initiative. The solicitation sought quotes for delivery of the chemical compounds to locations in the United States by September 2022, with...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded Reaction Biology Corporation a $11,304 purchase order contract to provide unspecified services or products in Malvern, Pennsylvania. As a component of NIH, NCATS works to develop innovations that enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of diseases and conditions. Reaction Biology Corporation will...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey. The order is for photoredox chemistry discovery services with a completion date of November 4, 2022. No set-aside designation was used for this award to support the National Center's programs in translational sciences. The potential value matches the award amount to...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to BIOIVT, LLC, a leading global provider of biological specimens and services. The $23,290 contract is for an in vitro transporter assessment of the COVID-19-related compound GS-441524, which is a potential oral treatment for COVID-19. The award supports NCATS' mission to advance the development of diagnostics and...